No one is the average patient. Doses are rounded to what a factory can produce. A pill split in half. A tablet a child cannot swallow. Four prescriptions where one would do. The patient adapts to the medicine, because the medicine cannot adapt to the patient
Everything around the pill became personal.
Care is connected. Diagnosis is data-driven. Treatment is guided by a patient’s own biology. A patient can move through an entirely personalized experience and still be handed the same fixed dose, in the same fixed form, as everyone else. The last mile never changed.
We know that system from the inside.
We spent years bringing a standardized ketamine medicine through the FDA’s ANDA process. We are proud of that work. We also learned what it costs to make one product for everyone — and what it means for the patients that product does not fit.
So we are changing the medicine itself.
Not the app. Not the packaging. The dose. The combination. The release profile. The form. Printed to a single prescription, and changed when the patient changes. That is PERSONALIZ3D™.
The printer is not the point.
The patient is the point. This has to work where medicine actually works: in qualified pharmacies, under professional oversight, with quality, consistency, and traceability. We are building a Center of Excellence to prove the formulations and the workflows, then putting both in the hands of pharmacy partners.
Not everything needs to be personal.
Standard medicine is essential, and it will remain the right answer for most patients. But when it is not the right answer, there has to be a real alternative. Every product, partnership, and decision answers one question: does this help the medicine adapt to the patient? If yes, it belongs here. If no, it does not.